You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

talazoparib

Showing 26 - 50 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Biopsy
  • Talazoparib
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Tumors, Breast Tumors Trial in Japan (talazoparib)

Active, not recruiting
Has Results
  • Neoplasms
  • Breast Neoplasms
  • talazoparib
  • Nagoya, Aichi, Japan
  • +7 more
Dec 20, 2021

Advanced Solid Tumor Trial in Worldwide (RP-3500, Talazoparib, Gemcitabine Injection [Gemzar])

Recruiting
  • Advanced Solid Tumor
  • Chicago, Illinois
  • +12 more
Nov 18, 2022

TNBC - Triple-Negative Breast Cancer Trial in United States (Gedatolisib, Talazoparib)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
Jan 18, 2022

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Talazoparib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 21, 2021

Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)

Terminated
Has Results
  • Solid Tumor
  • +6 more
  • Birmingham, Alabama
  • +8 more
Feb 16, 2022

Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +24 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

Metastatic Breast Cancer, Triple Negative Breast Cancer, Hormone Receptor Positive Tumor Trial in Indianapolis, Winston-Salem

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Sep 28, 2021

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in

Recruiting
  • Advanced Refractory Solid Tumors
  • +2 more
  • Singapore, Singapore
    National University Hospital
Aug 31, 2021

Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Oslo, Norway
    Oslo University Hospital
Feb 10, 2023

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • Rochester, New York
  • +4 more
Sep 17, 2021

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Cancer, Advanced Solid Tumor Trial in Kettering (lorlatinib, encorafenib + binimetinib, talazoparib)

Recruiting
  • Cancer
  • Advanced Solid Tumor
  • Kettering, Ohio
    Kettering Health Network
Oct 14, 2022

Prostate Cancer Metastatic Trial in Boston (Telaglenastat, Talazoparib)

Not yet recruiting
  • Prostate Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 27, 2021

Advanced Solid Tumors Trial in Worldwide (Talazoparib, Itraconazole, Rifampin)

Completed
Has Results
  • Advanced Solid Tumors
  • Talazoparib
  • +2 more
  • Budapest, Hungary
  • +6 more
Jun 1, 2021

Advanced Cancer, Metastatic Cancer, Breast Cancer Trial in United Kingdom, United States (ART4215, Talazoparib, Niraparib)

Recruiting
  • Advanced Cancer
  • +2 more
  • Orlando, Florida
  • +6 more
Aug 16, 2022

Cancer Trial in Worldwide (Talazoparib)

Completed
Has Results
  • Cancer
  • Talazoparib
  • Alhambra, California
  • +37 more
Jul 26, 2022

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Talazoparib
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021

TNBC - Triple-Negative Breast Cancer Trial in Seoul (Talazoparib, Placebo)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Talazoparib
  • Placebo
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Feb 14, 2021

Neuroendocrine Tumors Trial in Melbourne (Talazoparib)

Recruiting
  • Neuroendocrine Tumors
  • Talazoparib
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 20, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +5 more
Jan 12, 2023

Advanced Solid Tumors Trial in United States (Talazoparib)

Completed
Has Results
  • Advanced Solid Tumors
  • Talazoparib
  • Alhambra, California
  • +10 more
Feb 5, 2021